Literature DB >> 3494679

Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation.

G M Hänsch, M Seitz, M Betz.   

Abstract

Recently, we reported stimulation of rat macrophages and human platelets by isolated C5b-9 to synthesize prostaglandin E (PGE) or thromboxane B2 (TXB2). In the present study, we tested whether besides prostanoids, C5b-9 also would induce the production of other mediators. We found that C5b-9 in sublytic concentrations stimulated human granulocytes (polymorphonuclear leukocytes) or monocytes to release oxygen radicals. Furthermore, monocytes release interleukin-1 in response to C5b-9. Thus, besides having a lytic capacity, C5b-9 also functions as a stimulator of various cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494679     DOI: 10.1159/000234216

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  19 in total

1.  Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.

Authors:  I J Messias-Reason; S Y Hayashi; R M Nisihara; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.

Authors:  B J Czermak; A B Lentsch; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

3.  Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

Authors:  T E Mollnes; V Videm; J Riesenfeld; P Garred; J L Svennevig; E Fosse; K Hogasen; M Harboe
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 4.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

5.  Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

6.  C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

Authors:  Al Carrera-Marín; Z Romay-Penabad; E Papalardo; E Reyes-Maldonado; E García-Latorre; G Vargas; T Shilagard; S Pierangeli
Journal:  Lupus       Date:  2012-08-29       Impact factor: 2.911

Review 7.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

8.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.

Authors:  B Jahn; J Von Kempis; K L Krämer; S Filsinger; G M Hänsch
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.

Authors:  Constantino Fondevila; Xiu-Da Shen; Seiichiro Tsuchihashi; Yoichiro Uchida; Maria Cecilia Freitas; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

10.  Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.

Authors:  Wojciech Błogowski; Barbara Dołęgowska; Daria Sałata; Marta Budkowska; Leszek Domański; Teresa Starzyńska
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.